Completed Access to Information Requests

Follow:

  • RSS
  • Cite

    Cite

    APA

    Open Government - Government of Canada. (2017, December 10). Completed Access to Information Requests. Retrieved from http://open.canada.ca/en/search/ati?f%5B0%5D=ss_ati_organization_en%3AToronto%20Port%20Authority&amp%3Bamp%3Bati%5B0%5D=ss_ati_organization_en%3ACanada-Newfoundland%20and%20Labrador%20Offshore%20Petroleum%20Board&amp%3Bamp%3Bati%5B1%5D=ss_ati_organization_en%3ANatural%20Resources%20Canada&amp%3Bamp%3Bati%5B2%5D=ss_ati_organization_en%3AStatus%20of%20Women%20Canada&amp%3Bati%5B0%5D=ss_ati_organization_en%3AExport%20Development%20Canada&ati%5B0%5D=%3AAtlantic%20Canada%20Opportunities%20Agency&ati%5B1%5D=%3ACanadian%20Centre%20for%20Occupational%20Health%20and%20Safety&ati%5B2%5D=%3ADepartment%20of%20Justice%20Canada&ati%5B3%5D=%3AOffice%20of%20the%20Auditor%20General%20of%20Canada&ati%5B4%5D=ati_organization_en%3AHealth%20Canada&ati%5B5%5D=ati_organization_en%3AImmigration%2C%20Refugees%20and%20Citizenship%20Canada&ati%5B6%5D=ati_organization_en%3AToronto%20Port%20Authority&search_api_fulltext=&sort_by=year&sort_order=DESC&f%5B0%5D=ss_ati_organization_en%3AToronto%20Port%20Authority&page=7
    MLA

    “Completed Access to Information Requests.” Open Government - Government of Canada, 10 December 2017, http://open.canada.ca/en/search/ati?f%5B0%5D=ss_ati_organization_en%3AToronto%20Port%20Authority&amp%3Bamp%3Bati%5B0%5D=ss_ati_organization_en%3ACanada-Newfoundland%20and%20Labrador%20Offshore%20Petroleum%20Board&amp%3Bamp%3Bati%5B1%5D=ss_ati_organization_en%3ANatural%20Resources%20Canada&amp%3Bamp%3Bati%5B2%5D=ss_ati_organization_en%3AStatus%20of%20Women%20Canada&amp%3Bati%5B0%5D=ss_ati_organization_en%3AExport%20Development%20Canada&ati%5B0%5D=%3AAtlantic%20Canada%20Opportunities%20Agency&ati%5B1%5D=%3ACanadian%20Centre%20for%20Occupational%20Health%20and%20Safety&ati%5B2%5D=%3ADepartment%20of%20Justice%20Canada&ati%5B3%5D=%3AOffice%20of%20the%20Auditor%20General%20of%20Canada&ati%5B4%5D=ati_organization_en%3AHealth%20Canada&ati%5B5%5D=ati_organization_en%3AImmigration%2C%20Refugees%20and%20Citizenship%20Canada&ati%5B6%5D=ati_organization_en%3AToronto%20Port%20Authority&search_api_fulltext=&sort_by=year&sort_order=DESC&f%5B0%5D=ss_ati_organization_en%3AToronto%20Port%20Authority&page=7
    (Report an issue with citation)
About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA). For additional information, please see the “About Access to Information Requests” webpage.

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Current Search

Report Type

Organization

Disposition

Year

Month

Found 10274 record(s)

Req # A-2023-001363

Adverse Drug Reaction (ADR). Report number: 001051697.

Organization: Health Canada

7 page(s)
February 2024

Req # A-2015-000032

Documentation, forms, and paperwork relating to On-Site Evaluations done at Alexion Pharmaceuticals between December 3 - December 5 2008, Hoffman-La Roche between November 15 - November 20 2004, and Amgen Canada between February 12 - February 16 2007. Documentation, forms, and paperwork relating to Good Manufactoring Practice (GMP) inspections performed at Alexion Pharmaceuticals at October 29, 2013, Hoffman-La Roche at January 14th, 2013, and Amgen Canada at January 9th 2012.

Organization: Health Canada

301 page(s)
February 2024

Req # A-2018-001128

Any information pertaining to a recall, stop sale or any compliance and enforcement related activities involving Natural Product Number (NPN) 80037590 and NPN 80042116 licensed to Ferring Inc. from January 1, 2018 to November 13, 2018.

Organization: Health Canada

43 page(s)
February 2024

Req # A-2019-001814

Provide additional records for the Notice of Non-Compliance (NON) letter regarding liraglutide.

Organization: Health Canada

95 page(s)
February 2024

Req # A-2019-001949

All documentation related to the approval or access of Nurown in Canada or anything of relevance to communication between the Health Canada and Brainstorm Cell Therapeutics regarding Nurown since 2011 until March 24, 2020.

Organization: Health Canada

152 page(s)
February 2024

Req # A-2021-001996

Briefing notes and attachments regarding the January 17, 2022 authorization of PAXLOVID TM for patients with mild to moderate COVID-19 at high risk of developing serious disease from November 1, 2021 to February 1, 2022.

Organization: Health Canada

12 page(s)
February 2024

Req # A-2022-000881

All complaints posted against Lifeline Pharmaceuticals - in relation to health product advertising incidents. All information in relation to incidents received by Health Canada and those referred to an Advertising Preclearance Agency (APA) from 2021-01-01- 2022-09-27 in regards to product Misoprostol. All information in relation to complaints regarding the direct-to-consumer advertising of unauthorized claims.

Organization: Health Canada

720 page(s)
February 2024

Req # A-2022-000919

The Rothmans, Benson & Hedges submission in response to consultation on the proposed Regulations Amending the Tobacco Products Regulations published in the Canada Gazette Part I on June 11, 2022.

Organization: Health Canada

59 page(s)
February 2024

Req # A-2022-000996

The disclosable inspection document(s) listing the Inspector’s detailed observations, conditions found, and any follow-up expected by Health Canada for the human drugs drug establishment licence Good Pharmacovigilance Practices (GVP) inspection of the Gilead Sciences Canada facility (Site A) on Mississauga Road, Mississauga, Ontario starting around 19 July 2021. Reference Number 502703.

Organization: Health Canada

56 page(s)
February 2024

Req # A-2022-001027

The number of prescription requests for psychedelic drugs that were made and the number of prescriptions that were authorized by Health Canada since January 5, 2022.

Organization: Health Canada

4 page(s)
February 2024
Date modified: